Ironwood Pharmaceuticals, Inc. (IRWD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 11.41 |
| Open | 11.30 |
| Bid | 9.36 x 3200 |
| Ask | 25.00 x 900 |
| Day's Range | 11.21 - 11.52 |
| 52 Week Range | 10.13 - 14.27 |
| Volume | |
| Avg. Volume | 2,443,312 |
| Market Cap | 1.763B |
| Beta (5Y Monthly) | 1.13 |
| PE Ratio (TTM) | 3.72 |
| EPS (TTM) | 3.08 |
| Earnings Date | Aug 03, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.33 |
- Business Wire
Ironwood Pharmaceuticals to Present New IW-3300 and Linaclotide Data at Digestive Disease Week® 2022
BOSTON, May 09, 2022--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the company and its collaborators will present eight studies, including two oral presentations, during the Digestive Disease Week® (DDW) 2022 meeting being held from May 21 through May 24, 2022 in San Diego, CA.
- Zacks
Ironwood (IRWD) Q1 Earnings Miss, Linzess Growth Continues
Ironwood (IRWD) witnesses strong year-over-year sales growth on continued demand for Linzess. Its first-quarter earnings miss estimates. The company maintains revenue guidance for 2022. Stock declines.
- Zacks
Ironwood Pharmaceuticals (IRWD) Q1 Earnings Miss Estimates
Ironwood (IRWD) delivered earnings and revenue surprises of -22.22% and 2.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
